| Last Price | 14.33 | Max Price | 15.97 |
| Min Price | 0.10 | 1 Year return | 204.46 |
| Avg. Target | 0.00 | Expected Return | - |
| Sector | Health Care | Subsector | Biotechnology |
| Sell | 0 | Rating | |
| Hold | 0 | Concensus | |
| Buy | 0 |
Contact info:Country: Germany
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 2 | 136,070 | 0.00 % |
| 2020 | 2 | 153,065 | 0.00 % |
| 2021 | 14 | 227,669 | 0.01 % |
| 2022 | 0 | 260,393 | 0.00 % |
| 2023 | 0 | 215,054 | 0.00 % |
No Records Found
No Records Found
No Records Found
No Records Found
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
10.42
|
21.30
|
11.66
|
10.75
|
7.85
|
| Eps |
-2.53
|
-1.92
|
-2.48
|
-2.04
|
-2.05
|
| Price/earnings-ratio |
-4.12
|
-11.09
|
-4.70
|
-5.27
|
-7.66
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
3.47
|
6.28
|
4.00
|
5.24
|
3.70
|
| Market to book |
0.33
|
0.29
|
0.34
|
0.49
|
0.24
|
| Cashflow per stock |
-2.93
|
-1.20
|
-2.27
|
-1.38
|
-1.55
|
| Stocks |
4
|
7
|
7
|
9
|
10
|
| Market Cap |
45.92
|
151.68
|
83.03
|
98.84
|
158.89
|
|
Date
|
Price
|
|---|---|
|
01 May 2026
|
14.33
|
|
28 Apr 2026
|
14.12
|
|
21 Apr 2026
|
15.71
|
|
14 Apr 2026
|
15.97
|
|
28 Jan 2026
|
14.76
|
|
21 Dec 2025
|
0.10
|